-
September 26, 2019
Annual Report 2019 -
July 30, 2019
R&D Pipeline as of July 2019 -
July 30, 2019
The First Quarter of FY2019 (April 2019 - June 2019) -
May 8, 2019
Annual of FY2018 (April 2018 - March 2019) -
February 1, 2019
The Third Quarter of FY2018 (April 2018- December 2018)
-
September 20, 2019
Kissei Initiates Phase III Clinical Trial for Fostamatinib in Japanese Patients with Chronic Idiopathic Thrombocytopenic Purpura -
September 20, 2019
JCR Receives Marketing Approval in Japan for Darbepoetin Alfa BS Injection JCR, a Long-Acting Erythropoiesis-Stimulating Agent -
September 19, 2019
Launch of MINIRIN MELT® OD tablet 25µg and 50µg for the treatment of nocturia due to nocturnal polyuria in males -
June 18, 2019
Announcement of co-promotion agreement and Marketing Authorization approval in Japan for MINIRIN MELT® OD tablet 25µg and 50µg for treatment of nocturia due to nocturnal polyuria in males -
June 13, 2019
Launch of GLUBES® Combination Orally Disintegrating Tablet, a rapid-acting insulin secretagogue and agent for postprandial hyperglycemia
